Ignite Creation Date:
2024-05-06 @ 5:18 PM
Last Modification Date:
2024-10-26 @ 2:26 PM
Study NCT ID:
NCT05267600
Status:
COMPLETED
Last Update Posted:
2024-01-17
First Post:
2022-02-14
Brief Title:
A Phase 23 Study of Efgartigimod PH20 SC in Adult Participants with Bullous Pemphigoid
Sponsor:
argenx
Organization:
argenx
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-28
Completion Date Type:
ESTIMATED
First Submit Date:
2022-02-14
First Submit QC Date:
February 23 2022
Study First Post Date:
2022-03-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-01-17
Last Update Post Date Type:
ACTUAL